[HTML][HTML] Peer Reviewed: COVID-19 Severity and Mortality Among Chronic Liver Disease Patients: A Systematic Review and Meta-Analysis
R Nagarajan, Y Krishnamoorthy, S Rajaa… - Preventing Chronic …, 2022 - ncbi.nlm.nih.gov
Methods We searched for studies reporting COVID-19 outcomes among CLD and non-CLD
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
patients in databases including Medline, EMBASE, ScienceDirect, Google Scholar, and …
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19
AM Tizazu, HM Mengist, G Demeke - Immunity & Ageing, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused
by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is …
by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is …
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta …
A COVID-19 patient often presents with multiple comorbidities and is associated with
adverse outcomes. A comprehensive assessment of the prevalence of comorbidities in …
adverse outcomes. A comprehensive assessment of the prevalence of comorbidities in …
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
T Barbui, AM Vannucchi, A Alvarez-Larran, A Iurlo… - Leukemia, 2021 - nature.com
We report the clinical presentation and risk factors for survival in 175 patients with
myeloproliferative neoplasms (MPN) and COVID-19, diagnosed between February and …
myeloproliferative neoplasms (MPN) and COVID-19, diagnosed between February and …
Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study
M Henkens, AG Raafs, JAJ Verdonschot, M Linschoten… - BMC geriatrics, 2022 - Springer
Background Age and comorbidities increase COVID-19 related in-hospital mortality risk, but
the extent by which comorbidities mediate the impact of age remains unknown. Methods In …
the extent by which comorbidities mediate the impact of age remains unknown. Methods In …
[HTML][HTML] Ivermectin treatment may improve the prognosis of patients with COVID-19
MSI Khan, MSI Khan, CR Debnath… - Archivos de …, 2020 - ncbi.nlm.nih.gov
The pandemic coronavirus disease 19 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been spread rapidly worldwide with …
syndrome coronavirus 2 (SARS-CoV-2), has been spread rapidly worldwide with …
Short and long-term impact of COVID-19 infection on previous respiratory diseases
E Chiner-Vives, R Cordovilla-Perez… - Archivos de …, 2022 - Elsevier
Abstract On March 11, 2020, the World Health Organization declared Coronavirus Disease
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …
2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18 million) …
A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity
J Xu, W Xiao, X Liang, L Shi, P Zhang, Y Wang… - BMC public health, 2021 - Springer
Background Cardiovascular disease (CVD), one of the most common comorbidities of
coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse …
coronavirus disease 2019 (COVID-19), has been suspected to be associated with adverse …
Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
A Gupta, H Marzook, F Ahmad - Clinical and experimental medicine, 2023 - Springer
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes major
challenges to the healthcare system. SARS-CoV-2 infection leads to millions of deaths …
challenges to the healthcare system. SARS-CoV-2 infection leads to millions of deaths …
[HTML][HTML] Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release …
M Crespo, A Barrilado-Jackson, E Padilla… - American Journal of …, 2022 - Elsevier
Studies are urgently needed to characterize immunogenicity, efficacy, and safety of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in kidney …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in kidney …